4th CCP Phenogenomics Conference

19. 11. 2021 Event

15-16 September 2022, Vestec and on-line, Czech Republic The scientific committee has selected the topic of rare diseases: experimental models & delivery of therapies as the main thematic focus of this year Conference. REGISTRATION AND ABSTRACT SUBMISSION IS OPEN NOW The participation in the scientific part of the conference is free of charge for all…

TT 2022

17. 09. 2021 Event

17-20 September 2022, Helsinki, Finland / Hybrid Meeting – Attendance on-site with option to view sessions remotely. For registration and more information about the conference visit: Photo by Tapio Haaja on Unsplash

Global and European Infrastructures IMPC and INFRAFRONTIER Towards the Deciphering of Gene Functions for Human Health

21. 06. 2022 Event

18 October 2022, Brno, Czech Republic / Satellite event of the ICRI Conference The satellite event aims to showcase the scientific achievements and impact on various areas of human disease research and share its experience of the management of the scientific data produced, and describe how IMPC and INFRAFRONTIER with their resources and technologies strive…

International Conference on Research Infrastructures (ICRI 2022)

10. 12. 2021 Event

19-21 October 2022, Brno, Czech Republic / For more information visit Conference website. Brno will host the leading event in the field of research infrastructures – ICRI 2022 Press release, Brno, 8th December 2021 In October 2022, Brno will host a gathering of leaders in the field of research infrastructures – their users, policymakers, and…

International Congress of Research on Rare and Orphan Diseases – RE(ACT) Congress and IRDiRC Conference

27. 05. 2022 Event

15 – 18 March 2023, Berlin, Germany / This joint event continues the IRDiRC Conference series (5th edition) and the RE(ACT) Congress series (7th edition). It aims to bring together scientific leaders, experts, and young scientists from various breakthrough scientific fields to present cutting-edge research, exchange ideas, and discuss policies related to rare diseases research.…